<DOC>
	<DOC>NCT02948881</DOC>
	<brief_summary>The purpose of this study is to estimate the effect of oral Boniva (ibandronate sodium)taken once monthly versus placebo on bone quality and strength at the hip at one year.</brief_summary>
	<brief_title>A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Inclusion criteria: Ambulatory, postmenopausal women who are diagnosed with osteoporosis. Must be able to stand or sit upright for at least 60 minutes and swallow a tablet whole. Exclusion criteria: Have been treated with other bisphosphonates or using chronic steroids within the past 6 months. Have a history of major upper GI diseases or have severe kidney dysfunction. Have a spine fracture (identified on xray).</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>bisphosphonates</keyword>
	<keyword>bone</keyword>
</DOC>